Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 4 Grant or award Director acquired 51,063 shares (grant or award)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Shares withheld for taxes SVP and CFO gave up 4,791 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 12,628 shares (to pay taxes)
  5. 4 Shares withheld for taxes See Remarks gave up 4,791 shares (to pay taxes)
  6. 4 Grant or award Director acquired 18,292 shares (grant or award)
  7. 4 Grant or award Director acquired 18,292 shares (grant or award)
  8. 4 Grant or award Director acquired 18,292 shares (grant or award)
  9. 4 Grant or award Director acquired 18,292 shares (grant or award)
  10. 4 Grant or award Director acquired 18,292 shares (grant or award)
  11. 4 Shares withheld for taxes SVP and CFO gave up 1,821 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Executive Officer gave up 4,522 shares (to pay taxes)
  13. 4 Shares withheld for taxes See Remarks gave up 1,821 shares (to pay taxes)
  14. 4 Grant or award SVP and CFO acquired 16,000 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 47,000 shares (grant or award)
  16. 4 Grant or award See Remarks acquired 16,000 shares (grant or award)
  17. 4 Grant or award Director acquired 12,121 shares (grant or award)
  18. 4 Grant or award Director acquired 12,121 shares (grant or award)
  19. 4 Grant or award Director acquired 12,121 shares (grant or award)
  20. 4 Grant or award Director acquired 12,121 shares (grant or award)

Page 5 of 33 · 648 filings